Andra Ap Fonden Abb Vie Inc. Transaction History

Andra Ap Fonden

$6.64 Billion
Q3 2024

A detailed history of Andra Ap Fonden transactions in Abb Vie Inc. stock. As of the latest transaction made, Andra Ap Fonden holds 172,600 shares of ABBV stock, worth $30.2 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

172,600

Previous 230,700 25.18%

Holding current value

$30.2 Million

Previous $39.6 Million 13.86%

% of portfolio

0.51%

Previous 0.67%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $9.52 Million - $11.6 Million	-58,100 Reduced 25.18%	172,600 $34.1 Million
Q2 2024 Aug 07, 2024	SELL	$154.79 - $180.76 $7.89 Million - $9.22 Million	-51,000 Reduced 18.1%	230,700 $39.6 Million
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $24.2 Million - $27.6 Million	151,300 Added 116.03%	281,700 $51.3 Million
Q4 2023 Feb 15, 2024	BUY	$137.6 - $154.97 $11 Million - $12.4 Million	80,000 Added 158.73%	130,400 $20.2 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $1.79 Million - $2.07 Million	-13,400 Reduced 21.0%	50,400 $7.51 Million
Q2 2023 Aug 09, 2023	SELL	$132.51 - $164.9 $689,052 - $857,480	-5,200 Reduced 7.54%	63,800 $8.6 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $968,887 - $1.12 Million	6,700 Added 10.75%	69,000 $11 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $3.97 Million - $4.76 Million	-28,700 Reduced 31.54%	62,300 $10.1 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $617,366 - $708,078	-4,600 Reduced 4.81%	91,000 $12.2 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $2.64 Million - $3.36 Million	-19,200 Reduced 16.72%	95,600 $14.6 Million
Q4 2021 Feb 15, 2022	BUY	$107.43 - $135.93 $3.37 Million - $4.27 Million	31,400 Added 37.65%	114,800 $15.5 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $8.87 Million - $10.1 Million	83,400 New	83,400 $9 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $10.8 Million - $12 Million	-102,300 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $992,310 - $1.09 Million	-9,700 Reduced 8.66%	102,300 $11.1 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $869,292 - $1.17 Million	-10,800 Reduced 8.79%	112,000 $12 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $8,591 - $10,083	100 Added 0.08%	122,800 $10.8 Million
Q2 2020 Aug 06, 2020	BUY	$73.37 - $98.18 $1.66 Million - $2.22 Million	22,600 Added 22.58%	122,700 $12 Million
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $19,350 - $29,337	300 Added 0.3%	100,100 $7.63 Million
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $822,282 - $1.03 Million	-11,400 Reduced 10.25%	99,800 $8.84 Million
Q3 2019 Nov 19, 2019	BUY	$62.98 - $75.72 $1.35 Million - $1.62 Million	21,400 Added 23.83%	111,200 $8.42 Million
Q2 2019 Aug 15, 2019	BUY	$65.7 - $83.98 $407,340 - $520,676	6,200 Added 7.42%	89,800 $6.53 Million
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $671,118 - $789,873	-8,700 Reduced 9.43%	83,600 $6.74 Million
Q3 2018 Oct 16, 2018	SELL	$88.91 - $98.84 $453,441 - $504,084	-5,100 Reduced 5.24%	92,300 $8.73 Million
Q2 2018 Aug 17, 2018	BUY	$89.78 - $106.23 $1.26 Million - $1.49 Million	14,000 Added 16.79%	97,400 $9.02 Million
Q1 2018 Apr 10, 2018	BUY	$92.01 - $123.21 $634,869 - $850,149	6,900 Added 9.02%	83,400 $7.89 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $985,160 - $1.08 Million	-11,000 Reduced 12.57%	76,500 $7.4 Million
Q3 2017 Oct 31, 2017	BUY	$69.85 - $89.22 $6.11 Million - $7.81 Million	87,500	87,500 $7.78 Million

Others Institutions Holding ABBV

# of Institutions

3,855

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Andra Ap Fonden with notifications on news.

Account